Description: Ana Mingorance PhD is a neuroscientist, a patient advocate, and an independent consultant in genetic epilepsy syndromes and orphan drug development.
Hi, I’m Ana. I’m on a mission to make all diseases treatable, and to make the development of medicines sustainable.
Ana is a drug discovery strategist, working with companies and patient groups to make sure all patients have the medicines that they need.
Ana has 14 years of broad operational experience in biotech-pharma R&D and strategy (first at UCB Pharma and later as an independent consultant through her boutique consultancy firm Dracaena Consulting ), spanning indication selection, preclinical, clinical, regulatory and commercial stages. She has supported numerous programs at 15 bio-pharmaceutical companies, including 3 currently approved drugs and one preclinical-to-Phase 3 program. Ana is also the Founder of Singularity Bio , a biotech startup on a mi